Dr. Pier Paolo Claudio
TURNING SCIENTIFIC DISCOVERIES INTO PATIENT TREATMENTS
of Health, the CTSA program is aimed at speeding the time for laboratory discoveries to benefit patients. Xie and Claudio each received $25,000 to advance their research, encourage collaborations and spur innovative approaches to healthcare. A senior scientist at the Marshall Institute for Interdisciplinary Research, Xie will use his award to develop a method that may improve surgical repair of rotator cuff injuries. He will be working with Dr. Franklin D. Shuler, associate professor in the Department of Orthopaedics at the university’s Joan C. Edwards School of Medicine. Dr. Jingwei Xie
M
arshall scientists Dr. Jingwei Xie and Dr. Pier Paolo Claudio have received the first grants awarded through the Joint Pilot Research Program set up by Marshall and the University of Kentucky (UK) as part of their Clinical and Translational Science Award (CTSA) partnership. Funded by the National Institutes
Claudio, who is an associate professor in the Biomedical Sciences Graduate Program and the Departments of Biochemistry and Microbiology and Surgery at the medical school, will use his funds to help develop an assay that will potentially allow the development of personalized treatment for lung cancer. He will collaborate with Dr. Rolf J. Craven of UK’s Department of Molecular and Biomedical Pharmacology on the project. Xie and Claudio both intend to use their findings from these awards as springboards to apply for larger federal grants for related research.